Roche Holding AG (ROG.S) said on Wednesday the U.S. Food and Drug Administration (FDA) had approved its monoclonal antibody for treating COVID-19 in hospitalized adult patients.
The intravenous anti-inflammatory drug, Actemra, is a monoclonal antibody that reduces inflammation and was approved in 2010 to treat rheumatoid arthritis.
It is the first FDA-approved monoclonal antibody to treat COVID-19, Roche said.
RawNews1st is an independent digital news platform committed to delivering breaking news, crime reports, public safety updates, sports coverage, and the latest trending stories from across the United States. Our mission is to provide timely, accurate, and fact-based reporting that keeps readers informed about the stories shaping their communities and the nation. We believe in honest journalism, transparency, and delivering the facts—without unnecessary opinion or sensationalism. Stay informed with trusted news as it happens, only on RawNews1st.
